Outcomes of mitral valve re-replacement for bioprosthetic structural valve deterioration

被引:15
|
作者
Javadikasgari, Hoda [1 ]
Chemtob, Raphaelle A. [1 ]
Gillinov, A. Marc [1 ]
Pettersson, Gosta B. [1 ]
Lowry, Ashley M. [3 ]
Desai, Milind Y. [2 ]
Svensson, Lars G. [1 ]
Blackstone, Eugene H. [1 ,3 ]
Wierup, Per [1 ]
机构
[1] Cleveland Clin, Dept Thorac & Cardiovasc Surg, Heart Vasc & Thorac Inst, 9500 Euclid Ave,Desk J4-1, Cleveland, OH 44195 USA
[2] Cleveland Clin, Dept Cardiovasc Med, Heart Vasc & Thorac Inst, Cleveland, OH 44195 USA
[3] Cleveland Clin, Dept Quantitat Hlth Sci, Res Inst, Cleveland, OH 44195 USA
来源
关键词
heart valve replacement; outcomes research; causes of death; survival; RISK-FACTORS; SURGERY; IMPLANTATION; SOCIETY; GUIDELINES; EXPERIENCE; GRADIENT;
D O I
10.1016/j.jtcvs.2020.08.067
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: Reoperation for structural valve deterioration (SVD) of bioprosthetic mitral valves carries a presumed high operative risk, and transcatheter mitral valve-in-valve implantation has emerged as an alternative. However, surgical risk and long-term outcome following mitral valve re-replacement in these patients remain ill-defined. Hence, we sought to evaluate outcomes and long-term survival following surgical mitral valve re-replacement and to identify risk factors for mortality. Methods: From January 1990 to January 2017, 525 patients underwent surgical mitral valve re-replacement at Cleveland Clinic for bioprosthetic SVD: 133 (25%) isolated operations and 392 (75%) with concomitant procedures. Surgical complications and modes of death were compiled, long-term mortality assessed, and risk factors identified using a multivariable nonproportional hazards model and random forest analysis. Results: SVD was characterized by bioprosthetic regurgitation in 81% (425 out of 525) and stenosis in 44%(231 out of 525). One in-hospital death occurred after isolated valve re-replacement (0.75%) and 28 deaths occurred (7.1%; P =.003) after nonisolated re-replacement, 19 (68%) of which were from coagulopathy, vasoplegia, and multisystem organ failure. In the nonisolated group, incremental risk factors for time-related death after re-replacement included New York Heart Association functional class IV symptoms, concomitant coronary artery bypass grafting, prolonged cardiopulmonary bypass time, and transfusions. Conclusions: Mitral valve re-replacement for bioprosthetic SVD was associated with low surgical risk and excellent long-term survival. Isolated mitral valve re-replacement for bioprosthetic SVD had near-zero surgical risk. Excessive cardiopulmonary bypass duration and multiple transfusions correlated with increased early mortality in nonisolated procedures, as did preoperative severe heart failure. Optimal surgical plan and timing of surgery are keys to success.
引用
收藏
页码:1804 / +
页数:14
相关论文
共 50 条
  • [1] Prosthetic Valve-on-Valve Mitral Valve Re-Replacement: A Novel Approach
    Mathew, Sarin
    Bouchard, Melissa
    Hoschtitzky, J. Andreas
    ANNALS OF THORACIC SURGERY, 2018, 105 (01): : E25 - E26
  • [2] What prosthesis should be used at valve re-replacement after structural valve deterioration of a bioprosthesis?
    Lau, Lawrence
    Jamieson, Eric
    Hughes, Clifford
    Germann, Eva
    Chan, Florence
    ANNALS OF THORACIC SURGERY, 2006, 82 (06): : 2123 - 2132
  • [3] Mitral Valve Re-Replacement in a Patient with Osteogenesis Imperfecta
    Pfannmueller, B.
    Borger, M. A.
    Battellini, R. R.
    Mohr, F. W.
    THORACIC AND CARDIOVASCULAR SURGEON, 2010, 58 (08): : 486 - U72
  • [4] Annulus upsizing for mitral valve re-replacement in children
    Myers, Patrick O.
    del Nido, Pedro J.
    McElhinney, Doff B.
    Khalpey, Zain
    Lock, James E.
    Baird, Christopher W.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2013, 146 (02): : 347 - 351
  • [5] Redo surgical aortic valve replacement for bioprosthetic structural valve deterioration
    Raschpichler, Matthias
    Kiefer, Philip
    Otto, Wolfgang
    Noack, Thilo
    Gerber, Maria
    De Waha, Suzanne
    Dashkevich, Alexey
    Leontyev, Sergey
    Misfeld, Martin
    Borger, Michael A.
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2024, 66 (04)
  • [6] Treatment of Aortic, Mitral and Tricuspid Structural Bioprosthetic Valve Deterioration Using the Valve-in-Valve Technique
    Codner, Pablo
    Assali, Abid
    Vaknin-Assa, Hana
    Shapira, Yaron
    Orvin, Katia
    Sharony, Ram
    Sagie, Alexander
    Kornowski, Ran
    JOURNAL OF HEART VALVE DISEASE, 2015, 24 (03): : 345 - 352
  • [7] Emergency Valve Re-Replacement for Embolization of Prosthetic Mitral Valve Disc During Catheterization Procedure
    Pawale, Amit
    El-Eshmawi, Ahmed
    Tang, Gilbert H. L.
    Ellozy, Sharif H.
    Anyanwu, Anelechi C.
    ANNALS OF THORACIC SURGERY, 2013, 95 (05): : 1784 - 1787
  • [8] VALVE RE-REPLACEMENT IN THE ASYMPTOMATIC PATIENT
    COHN, LH
    ANNALS OF THORACIC SURGERY, 1991, 51 (03): : 357 - 358
  • [9] Transcatheter Valve-in-Valve Aortic Valve Replacement as an Alternative to Surgical Re-Replacement
    Deharo, Pierre
    Bisson, Arnaud
    Herbert, Julien
    Lacour, Thibaud
    Saint Etienne, Christophe
    Porto, Alizee
    Theron, Alexis
    Collart, Frederic
    Bourguignon, Thierry
    Cuisset, Thomas
    Fauchier, Laurent
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 76 (05) : 489 - 499
  • [10] Comparative analysis of structural valve deterioration and long-term clinical outcomes after bovine pericardial versus porcine bioprosthetic mitral valve replacement
    Kim, Woojung
    Hwang, Ho Young
    Kang, Yoonjin
    Kim, Ji Seong
    Sohn, Suk Ho
    Choi, Jae Woong
    Kim, Kyung Hwan
    JOURNAL OF THORACIC DISEASE, 2021, 13 (07) : 3969 - +